The painful impact of CMV
Approximately
50% of transplant patients develop symptomatic CMV infection in the
first 12 months, despite anti-viral prophylaxis.
CMV disease can add ~40% to the cost of a solid organ transplant.
Typical solid organ transplant costs US$200–700K depending on organ and relative health of the recipient.
The gift of life is precious -- transplant patients need our help
Despite
continued improvement in transplantation, CMV infection remains one of the leading causes of posttransplant morbidity and mortality
CMV viral load testing is critical to protect transplant patients
CMV viral load testing is routinely performed in a posttransplant setting to protect patients from CMV disease.
CMV DNA detection by PCR to monitor CMV viral load is:
-- The current standard in many transplant centers
-- Highly sensitive and rapid
-- Standardized against internationally accepted reference cut-offs
CMV DNA detection by PCR to monitor CMV viral load is:
-- The current standard in many transplant centers
-- Highly sensitive and rapid
-- Standardized against internationally accepted reference cut-offs
Learn how our portfolio can save lives
Dr. Tiziana Lazzarotto and Dr. Luciano Potena are passionate about their transplant patients. At the University of Bologna, they use QIAGEN’s artus viral load assays to measure viral infection and QuantiFERON-CMV to measure patients' immune response to CMV infection.
“Our task is to prevent the progression of a viral infection towards active disease. So if we diagnose an infection and see only a poor immune response to it, we need to help the patient by either reducing the immunosuppressant or initiating an antiviral therapy.”
“Our task is to prevent the progression of a viral infection towards active disease. So if we diagnose an infection and see only a poor immune response to it, we need to help the patient by either reducing the immunosuppressant or initiating an antiviral therapy.”